Transcription of SYMBICORT Prescribing Information
{{id}} {{{paragraph}}}
HIGHLIGHTS OF Prescribing INFORMATIONT hese highlights do not include all the Information needed to use SYMBICORT safely and effectively. See full Prescribing Information for (budesonide and formoterol fumarate dihydrate)Inhalation Aerosol, for oral inhalation useInitial Approval: 2006------------------------------------ ---- INDICATIONS AND USAGE ---------------------------------------- SYMBICORT is a combination product containing a corticosteroid and a long-acting beta2-adrenergic agonist indicated for: Treatment of asthma in patients 6 years of age and older.
5.3 Excessive Use of SYMBICORT and Use with Other Long-Acting Beta. 2-Agonists 5.4 Local Effects 5.5 Pneumonia and Other Lower Respiratory Tract 7.1 Inhibitors of Cytochrome P4503A4 Infections 7.2 Monoamine Oxidase Inhibitors and Tricyclic 5.6 Immunosuppression 5.7 Transferring Patients From Systemic Corticosteroid Therapy
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}